AI for humanity.
Inovia AI joined a 3-year project together with Elekta, SynteticMR and Linköping’s University with the purpose to increase the survivability of patients that are diagnosed with multi-metastases brain tumors.
Healthcare faces many challenges like improving patient outcome and working more cost-effectively in the face of growing demand, declining staff capacity and the rapid succession of new clinical and technological developments. The IMPACT project will address these challenges by building on preceding ITEA projects like MEDIATE and BENEFIT to add the next logical step: from evidence-based towards intelligence-based healthcare. To achieve intelligence-based healthcare the IMPACT project will promote automatic data collection and artificial intelligence throughout the complete clinical pathway.
Read more at Itea3 >
AI and Machine learning
What Inovia AI brings to the table.
By combining advanced AI and Big data technology, our goal is to improve the diagnoses and treatment optimization for each patient. By increasing the treatment effectiveness the result will give higher degree of survivability and improved quality of live for the patients. We will also shorten part of the process with the aim of up to 50% time reduction.
Vinnova and EU main sponsors.
The project is partly founded by Vinnova and partly the involved companies. It belongs to a larger European Union sponsored innovation program called IMPACT (Intelligence-based IMprovement of PersonAlized Treatment) and clinical workflow support. The development, research and results will be packaged into a product with the aim to help people in Europe and around the world.